| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 8.22e-05 | 46 | 100 | 4 | GO:0030020 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 2.20e-04 | 323 | 100 | 8 | GO:1901681 | |
| GeneOntologyMolecularFunction | serotonin-gated monoatomic cation channel activity | 2.46e-04 | 5 | 100 | 2 | GO:0022850 | |
| GeneOntologyMolecularFunction | serotonin receptor activity | 3.68e-04 | 6 | 100 | 2 | GO:0099589 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 3.68e-04 | 188 | 100 | 6 | GO:0005201 | |
| GeneOntologyMolecularFunction | collagen binding | 7.33e-04 | 81 | 100 | 4 | GO:0005518 | |
| GeneOntologyCellularComponent | complex of collagen trimers | 1.25e-04 | 21 | 98 | 3 | GO:0098644 | |
| GeneOntologyCellularComponent | somatodendritic compartment | MPL DIP2B FLNB MAP1A MAP6 NTRK2 ICA1 SREBF2 SRCIN1 PRRT2 CLCN2 PTPRF TNN CACNA1G CTNND1 PARD3 | 1.80e-04 | 1228 | 98 | 16 | GO:0036477 |
| GeneOntologyCellularComponent | serotonin-activated cation-selective channel complex | 2.16e-04 | 5 | 98 | 2 | GO:1904602 | |
| GeneOntologyCellularComponent | serotonin receptor complex | 2.16e-04 | 5 | 98 | 2 | GO:0098665 | |
| GeneOntologyCellularComponent | tRNA-splicing ligase complex | 5.98e-04 | 8 | 98 | 2 | GO:0072669 | |
| GeneOntologyCellularComponent | dendrite | DIP2B MAP1A MAP6 NTRK2 ICA1 SREBF2 SRCIN1 PRRT2 CLCN2 TNN CACNA1G CTNND1 | 6.72e-04 | 858 | 98 | 12 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | DIP2B MAP1A MAP6 NTRK2 ICA1 SREBF2 SRCIN1 PRRT2 CLCN2 TNN CACNA1G CTNND1 | 6.86e-04 | 860 | 98 | 12 | GO:0097447 |
| GeneOntologyCellularComponent | collagen trimer | 7.83e-04 | 88 | 98 | 4 | GO:0005581 | |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 1.39e-03 | 12 | 98 | 2 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 1.39e-03 | 12 | 98 | 2 | GO:0098643 | |
| Domain | Coact_PPARg | 1.62e-04 | 4 | 98 | 2 | IPR026784 | |
| Domain | Sec23/24_helical_dom | 4.03e-04 | 6 | 98 | 2 | IPR006900 | |
| Domain | Sec23_24_beta_S | 4.03e-04 | 6 | 98 | 2 | IPR012990 | |
| Domain | zf-Sec23_Sec24 | 4.03e-04 | 6 | 98 | 2 | PF04810 | |
| Domain | Sec23_trunk | 4.03e-04 | 6 | 98 | 2 | PF04811 | |
| Domain | Sec23_helical | 4.03e-04 | 6 | 98 | 2 | PF04815 | |
| Domain | Sec23_BS | 4.03e-04 | 6 | 98 | 2 | PF08033 | |
| Domain | Sec23/24_trunk_dom | 4.03e-04 | 6 | 98 | 2 | IPR006896 | |
| Domain | Znf_Sec23_Sec24 | 4.03e-04 | 6 | 98 | 2 | IPR006895 | |
| Domain | MeCpG-bd_2/3_C_dom | 5.63e-04 | 7 | 98 | 2 | IPR025884 | |
| Domain | MBD2/MBD3_p55-bd | 5.63e-04 | 7 | 98 | 2 | IPR032343 | |
| Domain | MBDa | 5.63e-04 | 7 | 98 | 2 | PF16564 | |
| Domain | MBD_C | 5.63e-04 | 7 | 98 | 2 | PF14048 | |
| Domain | - | 6.19e-04 | 74 | 98 | 4 | 3.40.50.410 | |
| Domain | - | 7.48e-04 | 8 | 98 | 2 | 3.30.890.10 | |
| Domain | Collagen | 1.04e-03 | 85 | 98 | 4 | IPR008160 | |
| Domain | Collagen | 1.04e-03 | 85 | 98 | 4 | PF01391 | |
| Domain | - | 1.19e-03 | 10 | 98 | 2 | 3.40.47.10 | |
| Domain | Thiolase-like | 1.19e-03 | 10 | 98 | 2 | IPR016039 | |
| Domain | PTB | 1.20e-03 | 40 | 98 | 3 | SM00462 | |
| Domain | Laminin_G_2 | 1.20e-03 | 40 | 98 | 3 | PF02210 | |
| Domain | PTB/PI_dom | 1.29e-03 | 41 | 98 | 3 | IPR006020 | |
| Domain | NC1_FIB | 1.45e-03 | 11 | 98 | 2 | PS51461 | |
| Domain | Fib_collagen_C | 1.45e-03 | 11 | 98 | 2 | PD002078 | |
| Domain | MBD | 1.45e-03 | 11 | 98 | 2 | SM00391 | |
| Domain | MBD | 1.45e-03 | 11 | 98 | 2 | PS50982 | |
| Domain | Methyl_CpG_DNA-bd | 1.45e-03 | 11 | 98 | 2 | IPR001739 | |
| Domain | Fib_collagen_C | 1.45e-03 | 11 | 98 | 2 | IPR000885 | |
| Domain | MBD | 1.45e-03 | 11 | 98 | 2 | PF01429 | |
| Domain | COLFI | 1.45e-03 | 11 | 98 | 2 | PF01410 | |
| Domain | DNA-bd_dom | 1.45e-03 | 11 | 98 | 2 | IPR016177 | |
| Domain | COLFI | 1.45e-03 | 11 | 98 | 2 | SM00038 | |
| Domain | - | 1.57e-03 | 95 | 98 | 4 | 2.60.120.200 | |
| Domain | LamG | 1.59e-03 | 44 | 98 | 3 | SM00282 | |
| Domain | VWF_A | 1.83e-03 | 99 | 98 | 4 | IPR002035 | |
| Domain | Gelsolin | 2.38e-03 | 14 | 98 | 2 | PF00626 | |
| Domain | Gelsolin-like_dom | 2.38e-03 | 14 | 98 | 2 | IPR007123 | |
| Domain | ATP_GRASP | 2.38e-03 | 14 | 98 | 2 | PS50975 | |
| Domain | PIN_domain-like | 2.38e-03 | 14 | 98 | 2 | IPR029060 | |
| Domain | ATP-grasp | 2.38e-03 | 14 | 98 | 2 | IPR011761 | |
| Domain | PKS_ER | 3.12e-03 | 16 | 98 | 2 | IPR020843 | |
| Domain | PKS_ER | 3.12e-03 | 16 | 98 | 2 | SM00829 | |
| Domain | Laminin_G | 3.51e-03 | 58 | 98 | 3 | IPR001791 | |
| Domain | PTPc_motif | 3.68e-03 | 59 | 98 | 3 | SM00404 | |
| Domain | Tyr_Pase_cat | 3.68e-03 | 59 | 98 | 3 | IPR003595 | |
| Domain | - | 3.95e-03 | 18 | 98 | 2 | 3.30.470.20 | |
| Domain | ADH_zinc_N | 4.40e-03 | 19 | 98 | 2 | PF00107 | |
| Domain | ADH_C | 4.40e-03 | 19 | 98 | 2 | IPR013149 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 3.61e-06 | 84 | 70 | 6 | M7098 | |
| Pathway | KEGG_FOCAL_ADHESION | 6.11e-06 | 199 | 70 | 8 | M7253 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | COL4A4 AAMP COL11A1 NTRK2 SHC1 COL5A3 PTPRF MAPK3 CTNND1 TNS3 | 3.82e-05 | 418 | 70 | 10 | MM15587 |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 4.91e-05 | 41 | 70 | 4 | MM15538 | |
| Pathway | WP_FOCAL_ADHESION | 5.68e-05 | 199 | 70 | 7 | M39402 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 6.51e-05 | 44 | 70 | 4 | M27812 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.36e-04 | 53 | 70 | 4 | MM14566 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 2.07e-04 | 59 | 70 | 4 | M27218 | |
| Pathway | BIOCARTA_TPO_PATHWAY | 2.20e-04 | 24 | 70 | 3 | M11520 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 2.35e-04 | 61 | 70 | 4 | MM14637 | |
| Pathway | PID_TRKR_PATHWAY | 2.35e-04 | 61 | 70 | 4 | M187 | |
| Pathway | BIOCARTA_TPO_PATHWAY | 2.49e-04 | 25 | 70 | 3 | MM1519 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 2.66e-04 | 63 | 70 | 4 | M11187 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | COL4A4 AAMP COL11A1 NTRK2 SHC1 COL5A3 PTPRF MAPK3 CTNND1 TNS3 | 2.78e-04 | 532 | 70 | 10 | M27870 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 2.83e-04 | 64 | 70 | 4 | M26953 | |
| Pathway | WP_FOCAL_ADHESION | 3.26e-04 | 187 | 70 | 6 | MM15913 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 3.38e-04 | 67 | 70 | 4 | MM15345 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 3.38e-04 | 67 | 70 | 4 | M26999 | |
| Pathway | WP_DYSREGULATED_MIRNA_TARGETING_IN_INSULINPI3KAKT_SIGNALING | 3.51e-04 | 28 | 70 | 3 | MM15957 | |
| Pathway | REACTOME_ISG15_ANTIVIRAL_MECHANISM | 3.91e-04 | 29 | 70 | 3 | MM17065 | |
| Pathway | WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING | 4.22e-04 | 71 | 70 | 4 | M39395 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 4.32e-04 | 30 | 70 | 3 | MM15517 | |
| Pathway | KEGG_ADHERENS_JUNCTION | 4.69e-04 | 73 | 70 | 4 | M638 | |
| Pathway | WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY | 4.96e-04 | 132 | 70 | 5 | M39338 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 5.25e-04 | 32 | 70 | 3 | MM14924 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 5.46e-04 | 76 | 70 | 4 | M27219 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 5.46e-04 | 76 | 70 | 4 | MM14573 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 6.33e-04 | 79 | 70 | 4 | M27643 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 6.48e-04 | 140 | 70 | 5 | M587 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 7.02e-04 | 300 | 70 | 7 | M610 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 8.34e-04 | 85 | 70 | 4 | M16441 | |
| Pathway | REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_RAS | 8.56e-04 | 9 | 70 | 2 | M27904 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 8.73e-04 | 38 | 70 | 3 | MM14969 | |
| Pathway | REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION | 9.43e-04 | 39 | 70 | 3 | M10735 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 1.03e-03 | 90 | 70 | 4 | M631 | |
| Pathway | REACTOME_SIGNAL_ATTENUATION | 1.07e-03 | 10 | 70 | 2 | M14236 | |
| Pathway | REACTOME_SIGNAL_ATTENUATION | 1.07e-03 | 10 | 70 | 2 | MM15440 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 1.09e-03 | 41 | 70 | 3 | M27778 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.17e-03 | 42 | 70 | 3 | M7169 | |
| Pathway | WP_NPHP1_DELETION_SYNDROME | 1.30e-03 | 11 | 70 | 2 | M48099 | |
| Pubmed | FLNB SLK NUMBL SHC1 PIKFYVE TXNL1 FASN AHNAK EIF4G1 CTNND1 AHNAK2 | 3.59e-11 | 216 | 100 | 11 | 31519766 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | FLNB SLK RTCB SHC1 NUBP1 PFAS YBX3 TACC2 MBD3 DARS2 DNAJA3 TXNL1 FASN AHNAK EIF4G1 DDX54 CTNND1 SEC23B SEC23A AHNAK2 | 3.25e-09 | 1415 | 100 | 20 | 28515276 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | FLNB AAMP SLK RTCB NUBP1 PFAS YBX3 TXNL1 FASN AHNAK EIF4G1 NFRKB NCOA7 ACAA2 HERC1 SEC23B SEC23A TNS3 AHNAK2 VAT1 | 5.20e-09 | 1455 | 100 | 20 | 22863883 |
| Pubmed | FLNB SLK VWF RTCB MCCC1 DARS2 AHNAK EIF4G1 ACAA2 AHNAK2 VAT1 | 7.82e-09 | 360 | 100 | 11 | 33111431 | |
| Pubmed | NUMBL SHC1 PFAS CACHD1 BANF1 KIAA1671 DNAJA3 TDRD3 PTPRE PTPRF AHNAK DDX54 MAPK3 CTNND1 HERC1 TNS3 VAT1 | 7.88e-09 | 1049 | 100 | 17 | 27880917 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | DIP2B THNSL1 SHC1 YBX3 TACC2 DARS2 KIAA1671 PIKFYVE DNAJA3 TXNL1 TDRD3 FAM120A PWP2 DDX54 ACAA2 HERC1 SEC23B SEC23A AHNAK2 VAT1 | 8.29e-09 | 1496 | 100 | 20 | 32877691 |
| Pubmed | DIP2B SLK NUMBL MAP6 NTRK2 MBD3 TDRD3 FRY FAM120A FAM120C EIF4G1 RACGAP1 MAPK3 CTNND1 PARD3 SEC23A | 1.62e-08 | 963 | 100 | 16 | 28671696 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | SLK MAP1A YBX3 MCCC1 MBD3 TDRD3 FAM120A FAM120C AHNAK EIF4G1 RACGAP1 CTNND1 TNS3 AHNAK2 | 2.15e-08 | 724 | 100 | 14 | 36232890 |
| Pubmed | 5.33e-08 | 118 | 100 | 7 | 30979931 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | FLNB RTCB PFAS YBX3 MCCC1 DNAJA3 FASN FAM120A AHNAK EIF4G1 DDX54 RACGAP1 ACAA2 CTNND1 PARD3 SEC23A TNS3 AHNAK2 | 5.54e-08 | 1353 | 100 | 18 | 29467282 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | SLK MAP1A RTCB NUMBL PFAS TACC2 MCCC1 KIAA1671 TDRD3 FASN AHNAK CIZ1 NCOA7 CTNND1 AHNAK2 | 7.38e-08 | 934 | 100 | 15 | 33916271 |
| Pubmed | 1.72e-07 | 209 | 100 | 8 | 36779422 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DIP2B RTCB NUMBL MCCC1 KIAA1671 AHNAK EIF4G1 RACGAP1 NCOA7 CTNND1 PARD3 SEC23B TNS3 AHNAK2 | 1.80e-07 | 861 | 100 | 14 | 36931259 |
| Pubmed | Substrate-trapping techniques in the identification of cellular PTP targets. | 3.06e-07 | 49 | 100 | 5 | 15588985 | |
| Pubmed | 4.58e-07 | 6 | 100 | 3 | 20442398 | ||
| Pubmed | RET finger protein enhances MBD2- and MBD4-dependent transcriptional repression. | 4.58e-07 | 6 | 100 | 3 | 17049487 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | FLNB SLK RTCB PFAS YBX3 MBD3 DARS2 DNAJA3 FASN FAM120A EIF4G1 PWP2 DDX54 RACGAP1 CTNND1 SEC23A VAT1 | 6.25e-07 | 1425 | 100 | 17 | 30948266 |
| Pubmed | 8.01e-07 | 7 | 100 | 3 | 15121188 | ||
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 8.02e-07 | 256 | 100 | 8 | 33397691 | |
| Pubmed | Identification and functional characterization of the p66/p68 components of the MeCP1 complex. | 1.91e-06 | 9 | 100 | 3 | 11756549 | |
| Pubmed | 2.79e-06 | 76 | 100 | 5 | 27542412 | ||
| Pubmed | FLNB RTCB PFAS FASN FAM120A AHNAK EIF4G1 PWP2 DDX54 SEC23B SEC23A | 2.94e-06 | 653 | 100 | 11 | 22586326 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | FLNB AAMP RTCB YBX3 LGALS8 KIAA1671 DNAJA3 FASN FAM120A AHNAK EIF4G1 PWP2 DDX54 RACGAP1 CTNND1 | 3.08e-06 | 1257 | 100 | 15 | 36526897 |
| Pubmed | FLNB SLK VWF MAP1A RTCB NUMBL MAP6 SRCIN1 FASN FAM120A FAM120C EIF4G1 PRICKLE2 MAPK3 CTNND1 SEC23A | 3.20e-06 | 1431 | 100 | 16 | 37142655 | |
| Pubmed | FLNB RTCB YBX3 BANF1 LGALS8 KIAA1671 TXNL1 AHNAK EIF4G1 RACGAP1 CTNND1 | 3.25e-06 | 660 | 100 | 11 | 32780723 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | HSPG2 SHC1 PFAS BANF1 MBD3 PIKFYVE TDRD3 FASN PTPRF AHNAK EIF4G1 HERC1 CHPF AHNAK2 | 3.43e-06 | 1105 | 100 | 14 | 35748872 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | FLNB CMPK1 RTCB COL5A3 MCCC1 FASN AHNAK EIF4G1 CACNA1G SEC23A AHNAK2 VAT1 | 3.65e-06 | 807 | 100 | 12 | 30575818 |
| Pubmed | ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure. | 3.74e-06 | 315 | 100 | 8 | 26777405 | |
| Pubmed | FLNB AAMP RTCB YBX3 BANF1 DNAJA3 FASN FAM120A EIF4G1 PWP2 DDX54 RACGAP1 VAT1 | 4.37e-06 | 971 | 100 | 13 | 33306668 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | FLNB SLK RTCB PFAS YBX3 BANF1 MBD3 DNAJA3 FASN FAM120A AHNAK EIF4G1 SEC23A VAT1 | 5.35e-06 | 1149 | 100 | 14 | 35446349 |
| Pubmed | 5.43e-06 | 40 | 100 | 4 | 22643896 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | CMPK1 RTCB MCCC1 BANF1 DARS2 DNAJA3 TXNL1 FASN FAM120A AHNAK EIF4G1 PWP2 DDX54 NFRKB SEC23B | 5.45e-06 | 1318 | 100 | 15 | 30463901 |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | FLNB SLK NUMBL SRCIN1 KIAA1671 FASN AHNAK EIF4G1 CTNND1 PARD3 | 5.53e-06 | 565 | 100 | 10 | 25468996 |
| Pubmed | FOXD1 is required for 3D patterning of the kidney interstitial matrix. | 6.46e-06 | 13 | 100 | 3 | 36335435 | |
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 19624305 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | FLNB RTCB KIAA1671 FASN PTPRF AHNAK EIF4G1 PWP2 DDX54 CIZ1 RACGAP1 CTNND1 SEC23A | 7.73e-06 | 1024 | 100 | 13 | 24711643 |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 7.79e-06 | 462 | 100 | 9 | 31138677 | |
| Pubmed | Dissecting the thrombopoietin receptor: functional elements of the Mpl cytoplasmic domain. | 8.18e-06 | 2 | 100 | 2 | 9122198 | |
| Pubmed | Cloning and functional characterization of mammalian homologues of the COPII component Sec23. | 8.18e-06 | 2 | 100 | 2 | 8898360 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 18093973 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 36037972 | ||
| Pubmed | Reduced mRNA expression levels of MBD2 and MBD3 in gastric carcinogenesis. | 8.18e-06 | 2 | 100 | 2 | 24338710 | |
| Pubmed | Structural analyses reveal that MBD3 is a methylated CG binder. | 8.18e-06 | 2 | 100 | 2 | 30980593 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 15007166 | ||
| Pubmed | Functions of the COPII gene paralogs SEC23A and SEC23B are interchangeable in vivo. | 8.18e-06 | 2 | 100 | 2 | 30065114 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 23361464 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 16034442 | ||
| Pubmed | Probing the dynamic distribution of bound states for methylcytosine-binding domains on DNA. | 8.18e-06 | 2 | 100 | 2 | 24307175 | |
| Pubmed | Closely related proteins MBD2 and MBD3 play distinctive but interacting roles in mouse development. | 8.18e-06 | 2 | 100 | 2 | 11274056 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 20833135 | ||
| Pubmed | p46Shc Inhibits Thiolase and Lipid Oxidation in Mitochondria. | 8.18e-06 | 2 | 100 | 2 | 27059956 | |
| Pubmed | DNA methylation directs genomic localization of Mbd2 and Mbd3 in embryonic stem cells. | 8.18e-06 | 2 | 100 | 2 | 27849519 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | FLNB AAMP SLK RTCB SHC1 PFAS MCCC1 TXNL1 FASN AHNAK EIF4G1 SEC23A TNS3 AHNAK2 VAT1 | 8.42e-06 | 1367 | 100 | 15 | 32687490 |
| Pubmed | COL11A1 RTCB YBX3 MBD3 LGALS8 FASN FAM120A FAM120C AHNAK EIF4G1 RACGAP1 CTNND1 PARD3 MBD2 SEC23A | 8.72e-06 | 1371 | 100 | 15 | 36244648 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | SLK SHC1 COL5A3 MBD3 DARS2 DNAJA3 ZCCHC4 EIF4G1 MAPK3 CTNND1 TNS3 C18orf32 | 1.22e-05 | 910 | 100 | 12 | 36736316 |
| Pubmed | 1.27e-05 | 267 | 100 | 7 | 33417871 | ||
| Pubmed | HSPG2 SLK RTCB YBX3 MCCC1 BANF1 KIAA1671 FAM120A EIF4G1 DDX54 NFRKB RACGAP1 HERC1 MBD2 SEC23B | 1.42e-05 | 1429 | 100 | 15 | 35140242 | |
| Pubmed | 1.70e-05 | 186 | 100 | 6 | 14744259 | ||
| Pubmed | Analysis of HIV-1 Gag protein interactions via biotin ligase tagging. | 1.82e-05 | 54 | 100 | 4 | 25631074 | |
| Pubmed | 1.98e-05 | 655 | 100 | 10 | 35819319 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DIP2B FLNB NUMBL SREBF2 SRCIN1 KIAA1671 CMIP THRA FAM120A PTPRE TESMIN FAM120C CTNND1 PARD3 GPT2 | 2.29e-05 | 1489 | 100 | 15 | 28611215 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | DIP2B FLNB RTCB SHC1 PFAS TXNL1 FASN FAM120A PTPRF DDX54 MAPK3 TNS3 | 2.38e-05 | 974 | 100 | 12 | 28675297 |
| Pubmed | 2.45e-05 | 534 | 100 | 9 | 35032548 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 14610093 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 14988395 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 10947852 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 25217205 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 19781662 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 21940993 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 21192076 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 12801637 | ||
| Pubmed | Protein tyrosine phosphatase epsilon inhibits signaling by mitogen-activated protein kinases. | 2.45e-05 | 3 | 100 | 2 | 12754301 | |
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 11553631 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 19232516 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 12419535 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 24849540 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 35196498 | ||
| Pubmed | Thrombopoietin signal transduction requires functional JAK2, not TYK2. | 2.45e-05 | 3 | 100 | 2 | 10224114 | |
| Pubmed | MPL CEP104 C10orf55 YBX3 KIAA1671 CMIP FAM120C EIF4G1 PARD3 AHNAK2 VAT1 | 2.81e-05 | 832 | 100 | 11 | 36724073 | |
| Pubmed | 2.82e-05 | 122 | 100 | 5 | 36929488 | ||
| Pubmed | 2.84e-05 | 417 | 100 | 8 | 19199708 | ||
| Pubmed | IFT27 AAMP MAP1A RTCB YBX3 MBD3 DARS2 DNAJA3 FASN FAM120A EIF4G1 CTNND1 SEC23B SEC23A | 2.86e-05 | 1335 | 100 | 14 | 29229926 | |
| Pubmed | 3.04e-05 | 549 | 100 | 9 | 38280479 | ||
| Pubmed | COL4A4 COL11A1 ICA1 SHC1 PFAS SRCIN1 COL25A1 ZCCHC4 GPT2 CHPF | 3.04e-05 | 689 | 100 | 10 | 36543142 | |
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | 4.13e-05 | 218 | 100 | 6 | 33378226 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 4.42e-05 | 444 | 100 | 8 | 34795231 | |
| Pubmed | Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. | 4.62e-05 | 327 | 100 | 7 | 15592455 | |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | 4.64e-05 | 580 | 100 | 9 | 35676659 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 4.77e-05 | 582 | 100 | 9 | 20467437 | |
| Pubmed | Non-redundant role of Shc in Erk activation by cytoskeletal reorganization. | 4.89e-05 | 4 | 100 | 2 | 14576154 | |
| Pubmed | ALOX15B controls macrophage cholesterol homeostasis via lipid peroxidation, ERK1/2 and SREBP2. | 4.89e-05 | 4 | 100 | 2 | 38581859 | |
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 22039050 | ||
| Pubmed | TANGO1/cTAGE5 receptor as a polyvalent template for assembly of large COPII coats. | 4.89e-05 | 4 | 100 | 2 | 27551091 | |
| Pubmed | A cluster of novel serotonin receptor 3-like genes on human chromosome 3. | 4.89e-05 | 4 | 100 | 2 | 14597179 | |
| Pubmed | Mechanism of TrkB-mediated hippocampal long-term potentiation. | 4.89e-05 | 4 | 100 | 2 | 12367511 | |
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 24184684 | ||
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 26253177 | ||
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 20602613 | ||
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 10627507 | ||
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 14585507 | ||
| Interaction | GBF1 interactions | FLNB SLK NUMBL PLEKHA4 SHC1 PIKFYVE TXNL1 FASN AHNAK EIF4G1 CTNND1 SEC23B AHNAK2 | 2.55e-07 | 442 | 99 | 13 | int:GBF1 |
| Interaction | RET interactions | NUMBL SHC1 TACC2 PTPRF NCOA7 MAPK3 CTNND1 SEC23B SEC23A VAT1 | 1.36e-06 | 284 | 99 | 10 | int:RET |
| Interaction | EPHA4 interactions | 4.10e-06 | 188 | 99 | 8 | int:EPHA4 | |
| Interaction | EFTUD2 interactions | FLNB SLK RTCB PLEKHA4 SHC1 PFAS YBX3 TACC2 MBD3 DARS2 HINFP DNAJA3 TXNL1 FASN AHNAK EIF4G1 DDX54 CTNND1 SEC23B SEC23A AHNAK2 | 5.99e-06 | 1449 | 99 | 21 | int:EFTUD2 |
| Interaction | STMN2 interactions | 8.31e-06 | 97 | 99 | 6 | int:STMN2 | |
| Interaction | NTRK3 interactions | DIP2B NTRK2 SHC1 BANF1 DNAJA3 MAPK3 CTNND1 PARD3 SEC23B SEC23A | 1.54e-05 | 374 | 99 | 10 | int:NTRK3 |
| Interaction | LCK interactions | DIP2B NUMBL PLEKHA4 SHC1 KIAA1671 PTPRF DDX54 MAPK3 CTNND1 PARD3 AHNAK2 | 1.71e-05 | 463 | 99 | 11 | int:LCK |
| Interaction | CIT interactions | FLNB CMPK1 RTCB PLEKHA4 PFAS BANF1 KIAA1671 DNAJA3 FASN FAM120A AHNAK EIF4G1 PWP2 RACGAP1 ACAA2 CTNND1 HERC1 PARD3 AHNAK2 VAT1 | 2.14e-05 | 1450 | 99 | 20 | int:CIT |
| Interaction | TOP3B interactions | HSPG2 PLEKHA4 SHC1 PFAS BANF1 MBD3 PIKFYVE TDRD3 FASN FAM120A PTPRF FAM120C AHNAK EIF4G1 RACGAP1 HERC1 CHPF SEC23B SEC23A AHNAK2 | 2.61e-05 | 1470 | 99 | 20 | int:TOP3B |
| Interaction | PHLPP1 interactions | 3.87e-05 | 333 | 99 | 9 | int:PHLPP1 | |
| Interaction | ATOH1 interactions | 4.64e-05 | 80 | 99 | 5 | int:ATOH1 | |
| Interaction | KIF20A interactions | FLNB RTCB PLEKHA4 SHC1 YBX3 BANF1 KIAA1671 FASN AHNAK PWP2 RACGAP1 CTNND1 HERC1 PARD3 AHNAK2 VAT1 | 5.15e-05 | 1052 | 99 | 16 | int:KIF20A |
| Interaction | CUL7 interactions | FLNB MAP1A RTCB PLEKHA4 MBD3 DNAJA3 FASN PTPRF AHNAK EIF4G1 PWP2 CIZ1 RACGAP1 SEC23A | 6.46e-05 | 845 | 99 | 14 | int:CUL7 |
| Interaction | FMR1 interactions | DIP2B NUMBL PLEKHA4 TACC2 MBD3 TDRD3 FAM120A FAM120C AHNAK EIF4G1 PARD3 | 6.48e-05 | 536 | 99 | 11 | int:FMR1 |
| Interaction | PYCR2 interactions | 7.75e-05 | 209 | 99 | 7 | int:PYCR2 | |
| Interaction | NAA40 interactions | SLK MAP1A RTCB NUMBL PFAS TACC2 MCCC1 KIAA1671 TDRD3 FASN AHNAK CIZ1 NCOA7 CTNND1 AHNAK2 | 8.26e-05 | 978 | 99 | 15 | int:NAA40 |
| Interaction | DYRK1A interactions | PLEKHA4 YBX3 CACHD1 MCCC1 FASN AHNAK EIF4G1 RACGAP1 CTNND1 SEC23A AHNAK2 | 8.42e-05 | 552 | 99 | 11 | int:DYRK1A |
| Interaction | PRX interactions | 8.89e-05 | 18 | 99 | 3 | int:PRX | |
| Interaction | YWHAH interactions | DIP2B RTCB NUMBL PLEKHA4 KIAA1671 THRA AHNAK EIF4G1 RACGAP1 NCOA7 CTNND1 HERC1 PARD3 SEC23B TNS3 AHNAK2 | 8.90e-05 | 1102 | 99 | 16 | int:YWHAH |
| Interaction | ACE2 interactions | HSPG2 FLNB AAMP CMPK1 RTCB NUMBL YBX3 BANF1 FASN PTPRF EIF4G1 DDX54 NCOA7 PARD3 SEC23A AHNAK2 | 9.29e-05 | 1106 | 99 | 16 | int:ACE2 |
| Interaction | GSK3A interactions | MAP1A PLEKHA4 PFAS KIAA1671 TXNL1 TDRD3 FAM120A DDX54 CTNND1 TNS3 | 9.50e-05 | 464 | 99 | 10 | int:GSK3A |
| Interaction | RTRAF interactions | 1.13e-04 | 222 | 99 | 7 | int:RTRAF | |
| Interaction | MEX3A interactions | 1.15e-04 | 384 | 99 | 9 | int:MEX3A | |
| Interaction | KLLN interactions | 1.42e-04 | 4 | 99 | 2 | int:KLLN | |
| Interaction | USP14 interactions | 1.46e-04 | 489 | 99 | 10 | int:USP14 | |
| Interaction | ITGB1 interactions | 1.57e-04 | 400 | 99 | 9 | int:ITGB1 | |
| Interaction | PML interactions | MAP1A NUMBL PLEKHA4 TACC2 FASN THRA FAM120A PTPRF AHNAK EIF4G1 NFRKB MAPK3 SEC23B AHNAK2 | 1.83e-04 | 933 | 99 | 14 | int:PML |
| Interaction | FCGR2B interactions | 1.90e-04 | 23 | 99 | 3 | int:FCGR2B | |
| Interaction | PEF1 interactions | 1.93e-04 | 108 | 99 | 5 | int:PEF1 | |
| Interaction | OTUD1 interactions | 1.93e-04 | 170 | 99 | 6 | int:OTUD1 | |
| Interaction | PFN1 interactions | MAP1A RTCB NUMBL PLEKHA4 KIAA1671 TDRD3 FASN ACAA2 MAPK3 AHNAK2 | 2.02e-04 | 509 | 99 | 10 | int:PFN1 |
| Interaction | KIF1B interactions | 2.13e-04 | 173 | 99 | 6 | int:KIF1B | |
| Interaction | GCSH interactions | 2.31e-04 | 61 | 99 | 4 | int:GCSH | |
| Interaction | HSPA9 interactions | FLNB SLK PLEKHA4 SHC1 PFAS TACC2 DNAJA3 FASN PTPRF TESMIN AHNAK HYI | 2.32e-04 | 727 | 99 | 12 | int:HSPA9 |
| Interaction | NTRK2 interactions | 2.33e-04 | 176 | 99 | 6 | int:NTRK2 | |
| Interaction | PIH1D1 interactions | FLNB SHC1 NUBP1 PFAS YBX3 TACC2 TXNL1 FASN FAM120C AHNAK SEC23B SEC23A | 2.44e-04 | 731 | 99 | 12 | int:PIH1D1 |
| Interaction | SEC16A interactions | 2.50e-04 | 426 | 99 | 9 | int:SEC16A | |
| Interaction | ACTB interactions | DIP2B FLNB MAP1A SYNJ2BP NUMBL SHC1 PFAS PRRT2 BANF1 MBD3 KIAA1671 PTPRF NFRKB CTNND1 MBD2 | 2.53e-04 | 1083 | 99 | 15 | int:ACTB |
| Interaction | SNAP25 interactions | 2.69e-04 | 116 | 99 | 5 | int:SNAP25 | |
| Interaction | ECHS1 interactions | 2.77e-04 | 257 | 99 | 7 | int:ECHS1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3q27 | 9.96e-06 | 128 | 101 | 5 | chr3q27 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr18q21 | 1.12e-03 | 205 | 101 | 4 | chr18q21 | |
| Cytoband | 10q26 | 1.18e-03 | 23 | 101 | 2 | 10q26 | |
| Cytoband | 3q27 | 1.39e-03 | 25 | 101 | 2 | 3q27 | |
| Cytoband | 3q27.1 | 1.62e-03 | 27 | 101 | 2 | 3q27.1 | |
| Cytoband | 3p24.3 | 1.62e-03 | 27 | 101 | 2 | 3p24.3 | |
| Cytoband | 1p34 | 2.28e-03 | 32 | 101 | 2 | 1p34 | |
| Cytoband | 12q13.12 | 3.20e-03 | 38 | 101 | 2 | 12q13.12 | |
| Cytoband | 18q21.1 | 3.20e-03 | 38 | 101 | 2 | 18q21.1 | |
| GeneFamily | Collagens | 1.41e-05 | 46 | 58 | 4 | 490 | |
| GeneFamily | 5-hydroxytryptamine receptors, ionotropic | 1.01e-04 | 5 | 58 | 2 | 172 | |
| GeneFamily | Zinc fingers CXXC-type|Methyl-CpG binding domain containing | 5.46e-04 | 11 | 58 | 2 | 1025 | |
| GeneFamily | PHD finger proteins|NuRD complex | 6.54e-04 | 12 | 58 | 2 | 1305 | |
| GeneFamily | PDZ domain containing | 1.43e-03 | 152 | 58 | 4 | 1220 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 2.04e-03 | 21 | 58 | 2 | 813 | |
| Coexpression | GSE22886_NEUTROPHIL_VS_MONOCYTE_DN | 1.01e-05 | 199 | 98 | 7 | M4467 | |
| Coexpression | GSE17721_POLYIC_VS_PAM3CSK4_4H_BMDC_DN | 1.04e-05 | 200 | 98 | 7 | M3833 | |
| Coexpression | LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER | 1.72e-05 | 216 | 98 | 7 | M4572 | |
| Coexpression | NABA_COLLAGENS | 2.03e-05 | 43 | 98 | 4 | MM17060 | |
| Coexpression | NABA_COLLAGENS | 2.22e-05 | 44 | 98 | 4 | M3005 | |
| Coexpression | GAUTAM_EYE_IRIS_CILIARY_BODY_CILIARY_BODY_CELLS | 3.93e-05 | 101 | 98 | 5 | M43624 | |
| Coexpression | TABULA_MURIS_SENIS_MESENTERIC_ADIPOSE_TISSUE_MESENCHYMAL_STEM_CELL_OF_ADIPOSE_AGEING | IFT27 MAP1A NUMBL YBX3 NUDT9 MBD3 FAM120A EIF4G1 ABHD8 MAPK3 VAT1 | 5.11e-05 | 685 | 98 | 11 | MM3782 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MID_MESOTHELIAL_CELL | HSPG2 FLNB SLK COL11A1 PLEKHA4 CACHD1 LGALS8 FRY PTPRE PTPRF NCOA7 ABHD8 CARNS1 | 5.64e-05 | 955 | 98 | 13 | M45680 |
| Coexpression | RIZKI_TUMOR_INVASIVENESS_3D_DN | 5.87e-05 | 262 | 98 | 7 | M11472 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_ILCP_CELL | 6.40e-05 | 182 | 98 | 6 | M45771 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_LATE_MESOTHELIAL_CELL | HSPG2 FLNB COL11A1 PLEKHA4 LGALS8 FRY PTPRE PTPRF NCOA7 CARNS1 AHNAK2 | 6.53e-05 | 704 | 98 | 11 | M45672 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | 6.77e-05 | 268 | 98 | 7 | M45796 | |
| Coexpression | GSE7509_FCGRIIB_VS_TNFA_IL1B_IL6_PGE_STIM_DC_UP | 7.01e-05 | 185 | 98 | 6 | M6823 | |
| Coexpression | NABA_CORE_MATRISOME | 7.09e-05 | 270 | 98 | 7 | MM17057 | |
| Coexpression | GSE7218_IGM_VS_IGG_SIGNAL_THGOUGH_ANTIGEN_BCELL_UP | 7.43e-05 | 187 | 98 | 6 | M6807 | |
| Coexpression | NABA_CORE_MATRISOME | 7.95e-05 | 275 | 98 | 7 | M5884 | |
| Coexpression | GSE16451_IMMATURE_VS_MATURE_NEURON_CELL_LINE_WEST_EQUINE_ENC_VIRUS_DN | 1.02e-04 | 198 | 98 | 6 | M7408 | |
| Coexpression | GSE17721_0.5H_VS_8H_LPS_BMDC_UP | 1.05e-04 | 199 | 98 | 6 | M4074 | |
| Coexpression | GSE21927_SPLEEN_C57BL6_VS_4T1_TUMOR_BALBC_MONOCYTES_UP | 1.08e-04 | 200 | 98 | 6 | M7594 | |
| Coexpression | GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP | 1.08e-04 | 200 | 98 | 6 | M9847 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 1.16e-07 | 170 | 100 | 7 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.89e-06 | 176 | 100 | 6 | 77516048aefbe1f48e825052756df0c310c1c486 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.29e-06 | 180 | 100 | 6 | e4add4c94f892a2d93926e5c6dac6a738319d091 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.51e-06 | 182 | 100 | 6 | a1c0e4090a9e7aa4941a40c817d178de144888b6 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.36e-06 | 189 | 100 | 6 | feedac2751ed770f80bc56fec31662b5b3826f58 | |
| ToppCell | Adult|World / Lineage, Cell type, age group and donor | 4.36e-06 | 189 | 100 | 6 | 5cd285bfad973125d46d704fec18b21266a63379 | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.63e-06 | 191 | 100 | 6 | ce76b156b153a2c7c9f2fb8e563b69c81073fbe5 | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.63e-06 | 191 | 100 | 6 | c006f5a6e3a32b79ac99a78304bdd5116fc0d5e0 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.92e-06 | 193 | 100 | 6 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.92e-06 | 193 | 100 | 6 | 471e65f02937bc18d7c5facdacdf1df58cf0f839 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.92e-06 | 193 | 100 | 6 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | Parenchymal-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.92e-06 | 193 | 100 | 6 | df4afb4848eb9d7d8d39e5c612919663cbbb2514 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.92e-06 | 193 | 100 | 6 | ab36d684bde8fe77d11a5188425135328052c58b | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-endo_venous_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.92e-06 | 193 | 100 | 6 | 84d1c1b7d3a1cb80f175527e3c89a2c3da7657f7 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.92e-06 | 193 | 100 | 6 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_mature|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.06e-06 | 194 | 100 | 6 | 8c88a0ddd61ad900426e312ca4ab13061c0380b8 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.22e-06 | 195 | 100 | 6 | 31353269591c9eee84872838e91995d4a035da46 | |
| ToppCell | Mesenchymal_cells-Arteriolar_fibro.|Mesenchymal_cells / Lineage and Cell class | 5.53e-06 | 197 | 100 | 6 | cb321836980e7b4efbb9284c6af7ccd34079d2be | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.69e-06 | 198 | 100 | 6 | 328f1d5d8168e05edd301d3a0f2eb5c6cd1c67c8 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 5.69e-06 | 198 | 100 | 6 | b8bd1ba268480f54451648e01631b615a3401144 | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.86e-06 | 199 | 100 | 6 | a13f4b8a039304e685464cc8879659824cad5a3e | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.86e-06 | 199 | 100 | 6 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 5.86e-06 | 199 | 100 | 6 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.03e-06 | 200 | 100 | 6 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Vein|LPS_only / Treatment groups by lineage, cell group, cell type | 6.03e-06 | 200 | 100 | 6 | b036f5e22c95a3b14391785b6e91aa183b9bc9a8 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.03e-06 | 200 | 100 | 6 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.03e-06 | 200 | 100 | 6 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.03e-06 | 200 | 100 | 6 | b70b7adb7c187e6253c7f0bb4c1f09c85ef7142c | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.03e-06 | 200 | 100 | 6 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | LPS-IL1RA+antiTNF-Unknown-Endothelial-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.55e-05 | 154 | 100 | 5 | 16fdafb5c64d2db321554f87129a962d113f1668 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-9|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.76e-05 | 167 | 100 | 5 | 013971700e80b71e4b8c79b8fff0d8beeac295c3 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell-Degenerative_endothelial_cell_-_unspecif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.57e-05 | 174 | 100 | 5 | 4d8c4a7d8f4972da68cebe0a79eb1a14ec546121 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.70e-05 | 175 | 100 | 5 | 442f261a3b2c4d2523f7d4089178f8c79cac2f0f | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.70e-05 | 175 | 100 | 5 | 35fb7735dd3355476fe60404833cb60bd066bcf1 | |
| ToppCell | P03-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.82e-05 | 176 | 100 | 5 | f3a54038cde58326f1caed96ecca33c141bcc8b3 | |
| ToppCell | AT1_cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 4.82e-05 | 176 | 100 | 5 | 4a30bb771297b30926fb98e2b5ec0dbdc46feac7 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.82e-05 | 176 | 100 | 5 | 96779273b94345250cf53ba671203345b43d9e00 | |
| ToppCell | Control|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.96e-05 | 177 | 100 | 5 | b8ff6940e31b749776e81ae4f5bbd577dba9749c | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.09e-05 | 178 | 100 | 5 | a3af5d9c55858e36be0498081029ecb0acaeb3d3 | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.09e-05 | 178 | 100 | 5 | b3b88989bd602cfb55bb5c47731deb99288a8952 | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 5.23e-05 | 179 | 100 | 5 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.23e-05 | 179 | 100 | 5 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | renal_papilla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 5.37e-05 | 180 | 100 | 5 | 49829e833fe6d2431cfd2e8f378c2aaa3b2b46a4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.37e-05 | 180 | 100 | 5 | d9dae9db8e17f6990032ee6cfa8393fae4768ca5 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.51e-05 | 181 | 100 | 5 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 5.51e-05 | 181 | 100 | 5 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.66e-05 | 182 | 100 | 5 | 573771130247e869e4e58f22d4a1cb31989635cf | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.66e-05 | 182 | 100 | 5 | 6cfaa2b3b3974c13b01c943f4adb70768dcc35e4 | |
| ToppCell | facs-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.80e-05 | 183 | 100 | 5 | d0721c6aa426953a520d40e976b6e65aa7ca65e8 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.96e-05 | 184 | 100 | 5 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.96e-05 | 184 | 100 | 5 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.96e-05 | 184 | 100 | 5 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | Control-Epithelial-ATI|World / Disease state, Lineage and Cell class | 6.11e-05 | 185 | 100 | 5 | 0563d5042bb96ecce8446fbf26d05ef7a45e23c5 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.27e-05 | 186 | 100 | 5 | 73cf266aeecd3cc15e8cb6094588a393bca8fbe6 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.27e-05 | 186 | 100 | 5 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | Control-Endothelial-Endothelial-Vein|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.27e-05 | 186 | 100 | 5 | 92092f11ecce22c14f244e42c499af0822977e6f | |
| ToppCell | COPD-Epithelial-ATI|COPD / Disease state, Lineage and Cell class | 6.27e-05 | 186 | 100 | 5 | df0977f6f48a2d4e11b59971f098b01204242f0f | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 6.43e-05 | 187 | 100 | 5 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | PND03|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.43e-05 | 187 | 100 | 5 | b3fcb36d853adfdea7172c5591de06f027e50af3 | |
| ToppCell | Control-Epithelial-ATI|Control / Disease state, Lineage and Cell class | 6.43e-05 | 187 | 100 | 5 | fdd1c57b61ca9392ac27661a82729f37593df63c | |
| ToppCell | critical-Myeloid-Monocyte-derived_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.43e-05 | 187 | 100 | 5 | 72e4aec49ea0c5fe6cee2a1a46369dbc90cd3fad | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_mature-endo_venous_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.43e-05 | 187 | 100 | 5 | 03de3c2df31bca0dc4e3718bada708d8fe8b69b9 | |
| ToppCell | Control-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 6.43e-05 | 187 | 100 | 5 | 5429ae85942b8ec3895cceb63c663de3c24ca064 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.59e-05 | 188 | 100 | 5 | 789d1be574e693d7bdd488f3c72c6df788e47b47 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.59e-05 | 188 | 100 | 5 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 | |
| ToppCell | Control-B_intermediate-6|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.76e-05 | 189 | 100 | 5 | 11cb9a16f1de8f60af2073ed7ea6d4f41c02f299 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.76e-05 | 189 | 100 | 5 | d9c2adbbe3e40eb8d57200b6411533e6685ea0d2 | |
| ToppCell | RA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 6.76e-05 | 189 | 100 | 5 | b6e12d24d2b0735730bdc625f8318c1c9c2a9b3b | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.76e-05 | 189 | 100 | 5 | 476226787c8ea0c9834a6f4c99ac7091cc20a455 | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 6.76e-05 | 189 | 100 | 5 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 6.76e-05 | 189 | 100 | 5 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.76e-05 | 189 | 100 | 5 | 3fe69bad6427e41b8d2dae450828cc21e9c3b3ad | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-bronchial_smooth_muscle_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.76e-05 | 189 | 100 | 5 | 4dc32b463546bbe7250dddd281b92ad17ec22da1 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Airway_Smooth_Muscle|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.76e-05 | 189 | 100 | 5 | 0d06bf0d7191d13a1c4f30a7881e7ea1093bfd6f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Astro|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.93e-05 | 190 | 100 | 5 | 78cc6c28b31de041c24175a98f47da256ecc15a2 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.93e-05 | 190 | 100 | 5 | 3a55cc5dc2549788bfe55f649686887b21a1fdd2 | |
| ToppCell | (4)_Endothelial_cells-(40)_EC-arterial|(4)_Endothelial_cells / Cell class and subclass of bone marrow stroma cells in homeostatis | 6.93e-05 | 190 | 100 | 5 | ff774faf3f12759d11e50ed7d189288bb79e22e1 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Astro-Astrocyte|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.93e-05 | 190 | 100 | 5 | e67d9400467b438592690b23d681e6c2fb8f09fd | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.93e-05 | 190 | 100 | 5 | b56c55f608b30f7379941ac7d5f0f5200f305fca | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.93e-05 | 190 | 100 | 5 | 106ea0bb7b99c697ffc5443d72343df2484250c7 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.93e-05 | 190 | 100 | 5 | 1c3d601422efa60fad8565f9ccd9032b847e4a91 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.11e-05 | 191 | 100 | 5 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.11e-05 | 191 | 100 | 5 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 7.11e-05 | 191 | 100 | 5 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | P03-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.28e-05 | 192 | 100 | 5 | be5e246b2350398b985767b2fbede17a8dd8cc44 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 7.28e-05 | 192 | 100 | 5 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-immature_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.28e-05 | 192 | 100 | 5 | 5af3b2b38495e925497c48f605d618bbf970965d | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 7.28e-05 | 192 | 100 | 5 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.28e-05 | 192 | 100 | 5 | 790282d4232311df3dac4ad97c80fc53443beccc | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.28e-05 | 192 | 100 | 5 | b2d9bffccd6264b4f12d88a0780646ee0b41969f | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.46e-05 | 193 | 100 | 5 | 3ea6b103e35bbb276e95301999618558fa3e38b1 | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 7.46e-05 | 193 | 100 | 5 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_mature-endo_capillary_(2)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.46e-05 | 193 | 100 | 5 | 4f38aae346ea3b4258744e9dc1e5aeb4fea13d06 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.46e-05 | 193 | 100 | 5 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.46e-05 | 193 | 100 | 5 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.46e-05 | 193 | 100 | 5 | af5108260783e69a7d67896c5bf64f862525926d | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 7.46e-05 | 193 | 100 | 5 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Vein|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.46e-05 | 193 | 100 | 5 | 7261c1ce30c796b61c6ec58e64a051baa24732ff | |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | 7.65e-05 | 194 | 100 | 5 | b6cc849fa08599bff9839ef382d190cc964e273e | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.65e-05 | 194 | 100 | 5 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| Disease | congenital dyserythropoietic anemia type II (implicated_via_orthology) | 1.09e-05 | 2 | 98 | 2 | DOID:0111401 (implicated_via_orthology) | |
| Disease | craniolenticulosutural dysplasia (implicated_via_orthology) | 1.09e-05 | 2 | 98 | 2 | DOID:0070307 (implicated_via_orthology) | |
| Disease | Osteochondrodysplasias | 3.31e-05 | 19 | 98 | 3 | C0029422 | |
| Disease | Roberts syndrome (implicated_via_orthology) | 6.52e-05 | 4 | 98 | 2 | DOID:5325 (implicated_via_orthology) | |
| Disease | essential thrombocythemia (is_implicated_in) | 1.62e-04 | 6 | 98 | 2 | DOID:2224 (is_implicated_in) | |
| Disease | reticulocyte measurement | FLNB VWF PLEKHA4 PFAS PIKFYVE DNAJA3 AHNAK EIF4G1 NCOA7 CTNND1 NYAP1 TNS3 | 1.94e-04 | 1053 | 98 | 12 | EFO_0010700 |
| Disease | leukodystrophy (implicated_via_orthology) | 3.87e-04 | 9 | 98 | 2 | DOID:10579 (implicated_via_orthology) | |
| Disease | schizophrenia (is_marker_for) | 4.26e-04 | 44 | 98 | 3 | DOID:5419 (is_marker_for) | |
| Disease | response to carboplatin, response to antineoplastic agent | 4.83e-04 | 10 | 98 | 2 | GO_0097327, GO_0097328 | |
| Disease | myopathy (implicated_via_orthology) | 5.51e-04 | 48 | 98 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | pyroglutamine measurement | 9.60e-04 | 58 | 98 | 3 | EFO_0005408 | |
| Disease | SARS-CoV-2 antibody measurement, response to COVID-19 vaccine | 1.17e-03 | 62 | 98 | 3 | EFO_0803360, EFO_0803362 | |
| Disease | Mental Retardation, Psychosocial | 1.21e-03 | 139 | 98 | 4 | C0025363 | |
| Disease | Profound Mental Retardation | 1.21e-03 | 139 | 98 | 4 | C0020796 | |
| Disease | Mental deficiency | 1.21e-03 | 139 | 98 | 4 | C0917816 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 1.27e-03 | 16 | 98 | 2 | C4551479 | |
| Disease | Spondyloepiphyseal Dysplasia | 1.27e-03 | 16 | 98 | 2 | C0038015 | |
| Disease | Schwartz-Jampel Syndrome | 1.27e-03 | 16 | 98 | 2 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 1.27e-03 | 16 | 98 | 2 | C0025237 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 1.27e-03 | 16 | 98 | 2 | C3541456 | |
| Disease | Van Buchem disease | 1.44e-03 | 17 | 98 | 2 | C0432272 | |
| Disease | carotid artery disease (is_marker_for) | 1.80e-03 | 19 | 98 | 2 | DOID:3407 (is_marker_for) | |
| Disease | osteochondrodysplasia (is_implicated_in) | 1.80e-03 | 19 | 98 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | Dyschondroplasias | 1.80e-03 | 19 | 98 | 2 | C0013366 | |
| Disease | bipolar disorder (is_marker_for) | 1.80e-03 | 19 | 98 | 2 | DOID:3312 (is_marker_for) | |
| Disease | Multiple Epiphyseal Dysplasia | 2.00e-03 | 20 | 98 | 2 | C0026760 | |
| Disease | Disproportionate short stature | 2.17e-03 | 77 | 98 | 3 | C0878659 | |
| Disease | sex interaction measurement, cerebral amyloid angiopathy | 2.20e-03 | 21 | 98 | 2 | EFO_0006790, EFO_0008343 | |
| Disease | reticulocyte count | 2.49e-03 | 1045 | 98 | 10 | EFO_0007986 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GGGKSRTGVMIPIPQ | 201 | Q8TD30 | |
| MGDGTPGRPKISVQQ | 26 | P60509 | |
| VLEPQEGVVGSMEGP | 66 | Q13685 | |
| GVKEPEVSAGQMPGP | 381 | A5X5Y0 | |
| PLLGGDVSAPEGTKM | 21 | Q8IY22 | |
| IKSAPVGPVAGGIMG | 1091 | Q5VU97 | |
| IGPPGDEGEMAIISQ | 956 | P53420 | |
| PLPGVMKLEFGAGAV | 546 | A5YM72 | |
| VTMPGIKVGGSGVNV | 246 | Q09666 | |
| MPGFKGEGPDVDVNL | 2776 | Q09666 | |
| MPGFKGEGPDVDVTL | 4326 | Q09666 | |
| IGIPGVKMEGGGAEV | 5241 | Q09666 | |
| VPQEMEGKPVLSGEA | 441 | O75952 | |
| KVIMINGGGPTALEP | 271 | Q96I13 | |
| GADMNGLPTKGPTEI | 56 | Q8TCD1 | |
| QVKGTVPEMEPPGAG | 341 | Q9Y6R0 | |
| GMVFGIPDGVLELVP | 486 | P98160 | |
| GPSIPKIMGLEGEQV | 96 | P53384 | |
| PEIGIPAEGKGMIDL | 596 | P23469 | |
| EIMEAGEPTGPILGA | 1101 | P78559 | |
| VVPGLLKGQGPMVQE | 466 | Q96JE9 | |
| TPLTAVPGLGEMGKE | 11 | Q9BY89 | |
| VQGLGVMPPKAGQTI | 1091 | Q6P4R8 | |
| VKTMDLPKGLQGVGP | 156 | O95983 | |
| LNTPMGPGRTVVVKG | 191 | O00214 | |
| GQSADGKMVPIIPGG | 4656 | Q15751 | |
| PLKEPSGVAGVDGML | 466 | Q8TDD1 | |
| GQKGEPAVVEPGMLV | 426 | P12107 | |
| GRGIEPTGNMVKQPA | 261 | O75369 | |
| AIPGGMVDPGEKISA | 211 | Q9BW91 | |
| GEQGDQGPRMVFPKI | 156 | Q9BXS0 | |
| GAMEEVPLKPGGGSI | 716 | Q8IYU2 | |
| PEGRQMTPVKGEPLG | 316 | Q9P265 | |
| RTEGVGPGVPGEVEM | 16 | P27361 | |
| GPGVPGEVEMVKGQP | 21 | P27361 | |
| GEVEMVKGQPFDVGP | 26 | P27361 | |
| AEGKGSQMGTVQPIP | 516 | Q9NZB2 | |
| GSKLPGQEGVRIQPM | 651 | Q7Z3G6 | |
| KTMELPKGLQGVGPG | 301 | Q9UBB5 | |
| MKGVEESPKVPGEGP | 11 | Q7Z6L0 | |
| ILGGQGKMPTVVSPE | 2056 | Q9Y2I7 | |
| EGPGEMGKPVVIPKE | 56 | Q10472 | |
| GGMLGEPEPLTEKAL | 411 | O60308 | |
| LINTPPGDQEKGEMG | 61 | Q5T013 | |
| GMDLVVKTVPVPDTG | 41 | Q9BW83 | |
| ELKLMDELAGPGGQP | 1946 | O43497 | |
| MEPPEGAGTGEIVKE | 1 | Q9H9R9 | |
| PEEATAMVGPPVKNG | 456 | Q8NCU4 | |
| IPPQGGKLEIAGMVV | 951 | Q9NX05 | |
| GGVPMGELFREITKP | 1351 | Q04637 | |
| QGGPLAPMTGTIEKV | 646 | Q96RQ3 | |
| PIPEGVNVGVASMGI | 76 | Q16553 | |
| PEGVEELVGKPAFVM | 151 | Q8N7U6 | |
| PPLGEGVVEGAGMVQ | 141 | Q17RN3 | |
| MKPLVVFVLGGPGAG | 1 | P30085 | |
| QKDGEPPMPVTGAVL | 511 | Q5TBA9 | |
| GLKMVVPGLDGAQIP | 1156 | P49327 | |
| PPSGGIMEKLQGIAE | 496 | Q9BQA5 | |
| VAEPMGEKPVGSLAG | 11 | O75531 | |
| IPPGTQTDQKIRMGG | 376 | Q96EY1 | |
| GIDGIRGPPGTVIMM | 431 | P25940 | |
| GDLGDMEPLKGTTPL | 921 | O60716 | |
| KLGQVPPGESVTAME | 1626 | P10586 | |
| MVKLVEVPNDGGPLG | 271 | Q8TEW0 | |
| GQVKEPVPTMALGEP | 401 | Q05084 | |
| GCGVGAPSPMVKIQL | 576 | Q6ZVC0 | |
| PGVRMIPVEIKEAGG | 151 | Q9Y4I5 | |
| SVGGGLQEPEAPEVM | 36 | Q6P0A1 | |
| IPVGVGSKGVIPMNA | 151 | Q9Y3I0 | |
| PAGQENPKMPTGEIE | 126 | Q6PI48 | |
| GQKLINKPMVGPEAG | 581 | Q9H2G2 | |
| NKPMVGPEAGGTKEV | 586 | Q9H2G2 | |
| IGVPNGEVEMPLKGR | 491 | Q9H7E2 | |
| DGKGVVGGVMIVTPN | 231 | Q8NI08 | |
| MVEDTLAGLGGPQKP | 486 | Q9H4M7 | |
| GEGDPSGIPIFMVLV | 111 | P57105 | |
| EDPQGTLVPDLGLGM | 531 | Q68CZ2 | |
| LPSGEMEVIFGVGPL | 106 | E7EW31 | |
| IPTLIGTPVKIGEGM | 336 | Q9H0H5 | |
| QGPGMVVGDELKTPI | 296 | Q15436 | |
| PTQGPGMVVGDELKI | 296 | Q15437 | |
| KEPEVSAGQMPGPGE | 381 | Q70Z44 | |
| QVDMKLPEGQVPEGA | 1886 | Q8IVF2 | |
| QPGMEVDVEAPGAKL | 3106 | Q8IVF2 | |
| QMDVKLPEGQVPEGA | 3701 | Q8IVF2 | |
| PGMAVVTLGEERPIG | 161 | Q8IZ52 | |
| APQAVGSGIPEMKTI | 156 | P51788 | |
| EAGGGMEKTLPEPVG | 496 | Q9ULV3 | |
| PMLQGLQGEGKLAPI | 46 | Q5SWW7 | |
| GGPDAVIIGMTKIPV | 496 | Q16620 | |
| IMGIGPVPAISGALK | 291 | P42765 | |
| EMKDGVPEGAQLQGP | 266 | P16989 | |
| PDMAQVTVGPGLLGV | 1471 | P04275 | |
| IAELESGGGSVPPMK | 1086 | Q9C0H9 | |
| GPMTGQEVAEVTVPK | 386 | Q9UQP3 | |
| GVAIPLPGVRKGDMS | 681 | Q15269 | |
| EAPEPGMEVVKVGGP | 441 | O15067 | |
| MGQEKVPIKQVPGGV | 306 | Q12772 | |
| SLVGDKNIILMGPPG | 51 | Q8IYQ7 | |
| KNIILMGPPGAGKTT | 56 | Q8IYQ7 | |
| GAGVGKEMAGVPPTL | 1511 | O95359 | |
| PSIIKAMGGSQPGEL | 136 | P40238 | |
| LPVTPGMEGAGVVIA | 106 | Q99536 | |
| DKGEGIIMVTDPPFG | 266 | Q9H5U6 | |
| VVVEMGSKPALTGEP | 566 | Q8TEC5 | |
| IGQSPIVSMPDGDKV | 196 | P10827 | |
| PGLGEKPEAGATVQM | 151 | A0A1B0GUJ8 | |
| VGQPVGGDPEVRKQM | 396 | P29353 | |
| MVGVKPVGSDPDFQP | 1 | O43396 | |
| EKVVGMVGALPVDDP | 116 | Q9UHE5 |